Mevalonate-driven constitutive trained immunity was further proposed to contribute to recurrent episodes of inflammatory symptoms in patients suffering from the hyper immunoglobulin D syndrome (HIDS), which is characterized by mevalonate kinase deficiency (MKD) accompanied by elevated mevalonate levels (Bekkering et al., 2018). This evidence concerns the gene MVK and mevalonic aciduria.